OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing
Renu Verma, Késia Esther da Silva, Neesha Rockwood, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 12, pp. 1486-1496
Open Access | Times Cited: 8
Renu Verma, Késia Esther da Silva, Neesha Rockwood, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 12, pp. 1486-1496
Open Access | Times Cited: 8
Showing 8 citing articles:
Genetic polymorphisms and anti-tuberculosis drug-induced liver injury: an umbrella review of the evidence
Jing-Ru C. Cheng, Jia Zhu, Ruina Chen, et al.
International Journal of Clinical Pharmacy (2025)
Closed Access
Jing-Ru C. Cheng, Jia Zhu, Ruina Chen, et al.
International Journal of Clinical Pharmacy (2025)
Closed Access
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
Marco Schiuma, Sofia Dinegro, Vera Battini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3881-3881
Open Access
Marco Schiuma, Sofia Dinegro, Vera Battini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3881-3881
Open Access
Genetic and Genomic Approaches to the Study of Drug‐Induced Liver Injury
Ann K. Daly
Liver International (2024) Vol. 45, Iss. 1
Open Access | Times Cited: 2
Ann K. Daly
Liver International (2024) Vol. 45, Iss. 1
Open Access | Times Cited: 2
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
Stefania Cheli, Alessandro Torre, Marco Schiuma, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 2
Stefania Cheli, Alessandro Torre, Marco Schiuma, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 2
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Levin Thomas, Arun Prasath Raju, Surulivelrajan Mallayasamy, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 5, pp. 541-557
Open Access | Times Cited: 1
Levin Thomas, Arun Prasath Raju, Surulivelrajan Mallayasamy, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 5, pp. 541-557
Open Access | Times Cited: 1
Another Step Closer to Genomic-informed Therapeutic Dosing for Tuberculosis Drugs
Paul K. Drain
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 12, pp. 1427-1428
Open Access
Paul K. Drain
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 12, pp. 1427-1428
Open Access
Exploring the Accuracy of Third-Generation Nanopore Se-quencing Technology for Detecting Mycobacterium Tuberculosis in Patients with Diabetes Mellitus
Chang Seob Song, Chunyan Zhao, Yingxing Nong, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116392-116392
Closed Access
Chang Seob Song, Chunyan Zhao, Yingxing Nong, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116392-116392
Closed Access
